Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Oxford Nanopore Technologies PLC ( (GB:ONT) ) has issued an update.
Oxford Nanopore Technologies plans to engage investors at two major March conferences, the Barclays Annual Global Healthcare Conference in Miami and the Berenberg UK Corporate Conference in Hertfordshire. The company will host analyst-led fireside chats and investor meetings, with a live and on-demand webcast of the Barclays session available via its investor relations site, underscoring its efforts to broaden institutional engagement and visibility in global healthcare and UK equity markets.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £1.70 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Spark’s Take on GB:ONT Stock
According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.
The score is driven primarily by moderate financial strength (revenue growth and strong equity base) offset by ongoing losses and negative cash flow. Technicals are supportive but look overextended, while valuation remains pressured by unprofitability. Earnings guidance is constructive, but sentiment includes meaningful operational challenges.
To see Spark’s full report on GB:ONT stock, click here.
More about Oxford Nanopore Technologies PLC
Oxford Nanopore Technologies plc is a life sciences company that develops nanopore-based molecular sensing technology for real-time, high-performance analysis of DNA and RNA. Its platforms, used in more than 125 countries, serve research across human, plant, animal, microbial and environmental biology, with growing applications in healthcare, food and agriculture.
Average Trading Volume: 1,715,243
Technical Sentiment Signal: Strong Sell
Current Market Cap: £1.11B
See more insights into ONT stock on TipRanks’ Stock Analysis page.

